Danish (OMX) Pharma Industry Analysis

UpdatedApr 18, 2026

DataAggregated Company Financials

Companies5

7D7.7%
3M-31.7%
1Y-35.6%
YTDn/a

In the last week, the Pharma industry is up 7.7%, with Novo Nordisk up 8.2%. In the past year, the industry is down 36%. Earnings are forecast to grow by 3.4% annually.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sat, 18 Apr 2026	DKK 1.2t	DKK 340.0b	DKK 106.8b	13.2x	11.6x	3.7x
Mon, 16 Mar 2026	DKK 1.2t	DKK 340.0b	DKK 106.8b	11.7x	11.1x	3.5x
Wed, 11 Feb 2026	DKK 1.5t	DKK 339.8b	DKK 106.7b	13.7x	13.9x	4.4x
Fri, 09 Jan 2026	DKK 1.7t	DKK 345.8b	DKK 108.6b	15.9x	16x	5x
Sun, 07 Dec 2025	DKK 1.5t	DKK 345.8b	DKK 108.6b	13.3x	13.5x	4.2x
Tue, 04 Nov 2025	DKK 1.5t	DKK 341.3b	DKK 115.5b	13.2x	12.9x	4.4x
Thu, 02 Oct 2025	DKK 1.7t	DKK 341.3b	DKK 115.5b	14.7x	14.9x	5x
Sat, 30 Aug 2025	DKK 1.7t	DKK 341.3b	DKK 115.5b	14.4x	14.5x	4.9x
Mon, 28 Jul 2025	DKK 2.1t	DKK 331.8b	DKK 108.8b	19.2x	19.2x	6.3x
Wed, 25 Jun 2025	DKK 2.1t	DKK 331.8b	DKK 108.8b	19.2x	19.2x	6.3x
Fri, 23 May 2025	DKK 2.1t	DKK 331.8b	DKK 108.8b	18.9x	18.9x	6.2x
Sun, 20 Apr 2025	DKK 1.9t	DKK 317.9b	DKK 104.9b	18.5x	18.4x	6.1x
Tue, 18 Mar 2025	DKK 2.5t	DKK 317.9b	DKK 104.9b	24x	23.7x	7.8x
Thu, 13 Feb 2025	DKK 2.7t	DKK 317.8b	DKK 104.9b	25.7x	25.5x	8.4x
Sat, 11 Jan 2025	DKK 2.9t	DKK 297.4b	DKK 98.2b	29.6x	29.3x	9.7x
Mon, 09 Dec 2024	DKK 3.6t	DKK 297.4b	DKK 98.2b	36.7x	36.2x	11.9x
Wed, 06 Nov 2024	DKK 3.4t	DKK 283.9b	DKK 93.2b	36.7x	36.3x	11.9x
Fri, 04 Oct 2024	DKK 3.6t	DKK 283.9b	DKK 93.2b	38.6x	38.1x	12.5x
Sun, 01 Sep 2024	DKK 4.2t	DKK 283.9b	DKK 93.2b	46.3x	45.6x	15x
Tue, 30 Jul 2024	DKK 4.0t	DKK 269.3b	DKK 92.2b	43.9x	43.3x	14.8x
Thu, 27 Jun 2024	DKK 4.5t	DKK 269.3b	DKK 92.2b	50x	49.2x	16.8x
Sat, 25 May 2024	DKK 4.2t	DKK 269.3b	DKK 92.2b	46.2x	45.4x	15.6x
Mon, 22 Apr 2024	DKK 3.9t	DKK 257.0b	DKK 86.4b	46.2x	45.4x	15.3x
Wed, 20 Mar 2024	DKK 4.1t	DKK 257.0b	DKK 86.4b	47.8x	47x	15.8x
Fri, 16 Feb 2024	DKK 3.8t	DKK 257.0b	DKK 86.4b	45.3x	44.5x	15x
Sun, 14 Jan 2024	DKK 3.3t	DKK 238.8b	DKK 78.2b	42.9x	42.1x	13.8x
Tue, 12 Dec 2023	DKK 3.0t	DKK 238.8b	DKK 78.2b	39.6x	38.8x	12.7x
Thu, 09 Nov 2023	DKK 3.2t	DKK 238.6b	DKK 78.1b	42.4x	41.5x	13.6x
Sat, 07 Oct 2023	DKK 2.9t	DKK 225.4b	DKK 70.1b	42.9x	42x	13x
Mon, 04 Sep 2023	DKK 3.0t	DKK 225.4b	DKK 70.1b	43.3x	42.3x	13.2x
Wed, 02 Aug 2023	DKK 2.5t	DKK 211.8b	DKK 63.8b	40.3x	39.4x	11.9x
Fri, 30 Jun 2023	DKK 2.4t	DKK 211.8b	DKK 63.8b	39.1x	38.2x	11.5x
Sun, 28 May 2023	DKK 2.6t	DKK 211.8b	DKK 63.8b	41.8x	40.8x	12.3x
Tue, 25 Apr 2023	DKK 2.6t	DKK 199.9b	DKK 57.8b	51.5x	45.9x	13.3x

Price to Earnings Ratio

45.9x

Tue, 25 Apr 2023

Current Industry PE

Investors are pessimistic on the Danish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 11.6x which is lower than its 3-year average PE of 31.3x.

The 3-year average PS ratio of 10.2x is higher than the industry's current PS ratio of 3.7x.

Past Earnings Growth

The earnings for companies in the Pharmaceuticals industry have grown 23% per year over the last three years.
Revenues for these companies have grown 19% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Danish Pharma compare with similar industries?


DK Market	2.96%
Healthcare	7.16%
Pharma	7.73%
Pharma	7.73%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
NOVO B Novo Nordisk	DKK 260.40	8.2% +DKK 87.4b	-38.2%	PE11.3x
HLUN B H. Lundbeck	DKK 42.44	5.1% +DKK 2.0b	48.6%	PE13.2x
PEG Pharma Equity Group	DKK 0.088	4.3% +DKK 4.4m	3.9%	PB4.2x